Adaptive Biotechnologies Corp (ADPT)
4.445
+0.02
(+0.57%)
USD |
NASDAQ |
Nov 21, 14:37
Adaptive Biotechnologies Price: 4.445 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 4.42 | 4.565 | 4.33 | 4.42 | 1.819M |
Nov 19, 2024 | 4.58 | 4.64 | 4.38 | 4.48 | 1.709M |
Nov 18, 2024 | 5.01 | 5.10 | 4.66 | 4.68 | 1.393M |
Nov 15, 2024 | 5.63 | 5.788 | 5.07 | 5.08 | 1.462M |
Nov 14, 2024 | 5.85 | 5.95 | 5.53 | 5.58 | 888187.0 |
Nov 13, 2024 | 6.00 | 6.08 | 5.835 | 5.85 | 1.142M |
Nov 12, 2024 | 6.23 | 6.49 | 5.89 | 5.93 | 1.149M |
Nov 11, 2024 | 6.00 | 6.70 | 5.99 | 6.49 | 1.868M |
Nov 08, 2024 | 6.00 | 6.33 | 5.60 | 5.82 | 1.383M |
Nov 07, 2024 | 5.79 | 6.03 | 5.515 | 5.63 | 1.776M |
Nov 06, 2024 | 5.64 | 5.80 | 5.465 | 5.75 | 1.159M |
Nov 05, 2024 | 5.17 | 5.59 | 5.09 | 5.58 | 837230.0 |
Nov 04, 2024 | 5.30 | 5.53 | 5.16 | 5.26 | 1.160M |
Nov 01, 2024 | 4.90 | 5.33 | 4.84 | 5.31 | 959037.0 |
Oct 31, 2024 | 5.03 | 5.07 | 4.83 | 4.84 | 1.598M |
Oct 30, 2024 | 4.65 | 5.10 | 4.65 | 5.06 | 597927.0 |
Oct 29, 2024 | 4.60 | 4.73 | 4.555 | 4.71 | 818524.0 |
Oct 28, 2024 | 4.49 | 4.71 | 4.48 | 4.67 | 879141.0 |
Oct 25, 2024 | 4.53 | 4.665 | 4.44 | 4.45 | 610278.0 |
Oct 24, 2024 | 4.78 | 4.80 | 4.47 | 4.52 | 665790.0 |
Oct 23, 2024 | 4.66 | 4.76 | 4.565 | 4.72 | 568147.0 |
Oct 22, 2024 | 4.55 | 4.775 | 4.46 | 4.70 | 741839.0 |
Oct 21, 2024 | 4.61 | 4.62 | 4.445 | 4.55 | 968408.0 |
Oct 18, 2024 | 4.66 | 4.80 | 4.63 | 4.68 | 927097.0 |
Oct 17, 2024 | 4.79 | 4.815 | 4.60 | 4.64 | 910616.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.335
Minimum
Apr 18 2024
67.74
Maximum
Jan 22 2021
20.71
Average
9.92
Median
Jan 18 2023
Price Benchmarks
The Cooper Companies Inc | 99.56 |
NovaBay Pharmaceuticals Inc | 0.70 |
Palatin Technologies Inc | 0.9146 |
iBio Inc | 2.39 |
Theriva Biologics Inc | 1.24 |
Price Related Metrics
PS Ratio | 3.671 |
Price to Book Value | 2.931 |
Earnings Yield | -30.15% |
Market Cap | 655.99M |